Espey MG, Chernyshev ON, Reinhard JF Jr, Namboodiri MA, Colton
CA (1997) Activated human microglia produce the excitotoxin
quinolinic acid. Neuroreport 8:431– 434.
Furuya T, Hayakawa H, Yamada M, Yoshimi K, Hisahara S, Miura M,
Mizuno Y, Mochizuki H (2004) Caspase-11 mediates inflammatory
dopaminergic cell death in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. J Neurosci
24:1865–1872.
Gao HM, Jiang J, Wilson B, Zhang W, Hong JS, Liu B (2002) Microglial
activation-mediated delayed and progressive degeneration of rat
nigral dopaminergic neurons: relevance to Parkinson's disease.
J Neurochem 81:1285–1297.
Gayle DA, Ling Z, Tong C, Landers T, Lipton JW, Carvey PM (2002)
Lipopolysaccharide (LPS)-induced dopamine cell loss in culture:
roles of tumor necrosis factor-alpha, interleukin-1beta, and nitric
oxide. Brain Res Dev Brain Res 133:27–35.
Han IO, Kim KW, Ryu JH, Kim WK (2002) p38 Mitogen-activated
protein kinase mediates lipopolysaccharide, not interferon-gamma,
-induced inducible nitric oxide synthase expression in mouse BV2
microglial cells. Neurosci Lett 325:9 –12.
Hartmann A, Hunot S, Hirsch EC (2003) Inflammation and dopaminergic neuronal loss in Parkinson's disease: a complex matter. Exp
Neurol 184:561–564.
Herrera AJ, Castaño A, Venero JL, Cano J, Machado A (2000) The
single intranigral injection of LPS as a new model for studying the
selective effects of inflammatory reactions on dopaminergic system. Neurobiol Dis 7:429 – 447.
Hirsch EC, Breidert T, Rousselet E, Hunot S, Hartmann A, Michel PP
(2003) The role of glial reaction and inflammation in Parkinson's
disease. Ann N Y Acad Sci 991:214 –228.
Hisahara S, Yuan J, Momio T, Okano H, Miura M (2001) Caspase-11
mediates oligodendrocyte cell death and pathogenesis of autoimmune-mediated demyelination. J Exp Med 193:111–122.
Hunot S, Dugas N, Faucheux B, Hartmann A, Tardieu M, Debre P,
Agid Y, Dugas B, Hirsch EC (1999) FcepsilonRII/CD23 is ex- pressed in Parkinson's disease and induces, in vitro, production of
nitric oxide and tumor necrosis factor-alpha in glial cells. J Neurosci
19:3440 –3447.
Hur J, Kim SY, Kim H, Cha S, Lee MS, Suk K (2001) Induction of
caspase-11 by inflammatory stimuli in rat astrocytes: lipopolysaccharide induction through p38 mitogen-activated protein kinase
pathway. FEBS Lett 26:157–162.
Iravani MM, Kashefi K, Mander P, Rose S, Jenner P (2002) Involvement of inducible nitric oxide synthase in inflammation-induced
dopaminergic neurodegeneration. Neuroscience 110:49 –58.
Iravani MM, Leung CC, Sadeghian M, Haddon CO, Rose S, Jenner P
(2005) The acute and the long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell
activation. Eur J Neurosci 22(2):317–330.
Jeohn GH, Cooper CL, Wilson B, Chang RC, Jang KJ, Kim HC, Liu B,
Hong JS (2002) p38 MAP kinase is involved in lipopolysaccharideinduced dopaminergic neuronal cell death in rat mesencephalic
neuron-glia cultures. Ann N Y Acad Sci 62:332–346.
Kang SJ, Wang S, Hara H, Peterson EP, Namura S, Amin-Hanjani S,
Huang Z, Srinivasan A, Tomaselli KJ, Thornberry NA, Moskowitz
MA, Yuan J (2000) Dual role of caspase-11 in mediating activation
of caspase-1 and caspase-3 under pathological conditions. J Cell
Biol 149:613– 622.
Kang SJ, Wang S, Kuida K, Yuan J (2002) Distinct downstream
pathways of caspase-11 in regulating apoptosis and cytokine maturation during septic shock response. Cell Death Differ
9:1115–1125.
Kim WG, Mohney RP, Wilson B, Jeohn GH, Liu B, Hong JS (2000)
Regional difference in susceptibility to lipopolysaccharide-induced
neurotoxicity in the rat brain: role of microglia. J Neurosci
20:6309 – 6316.
Kim EJ, Kwon KJ, Park JY, Lee SH, Moon CH, Baik EJ (2002)
Neuroprotective effects of prostaglandin E2 or cAMP against mi-
